公司资料
Aura Biosciences 股价、新闻与催化剂
- 股票代码:
- AURA
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
6.09 USD (+0.83%)
收盘价
最后更新: 2026年10月2日
713M USD
市值
股价为何变动
截至 2026年10月2日，AURA 上涨 0.83%，收于 $6.09。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
业务概览
Aura Biosciences is a biotechnology company focused on precision oncology and tumor-targeting therapies. Its story is built around using targeted biologics to deliver treatment specifically to tumors.
所在地与行业分类
Aura Biosciences is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商业模式特征
The company depends on clinical data, translational validation, and the ability to develop a narrow but differentiated cancer pipeline. Investors usually watch efficacy, safety, and strategic milestones.
生物医药行业定位
Aura occupies a precision-oncology niche within biotech. It is catalyst-sensitive because the market needs evidence that the targeted approach can create real clinical value.
未来催化剂
- Aura Biosciences’s catalysts are bel-sar and the ocular-oncology platform, where the next clinical update can materially change the story. The market cares about whether the platform keeps differentiating itself.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。